These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 33014154)
41. Elevated expression of UBE2T in lung cancer tumors and cell lines. Hao J; Xu A; Xie X; Hao J; Tian T; Gao S; Xiao X; He D Tumour Biol; 2008; 29(3):195-203. PubMed ID: 18667844 [TBL] [Abstract][Full Text] [Related]
42. Functions of three ubiquitin-conjugating enzyme 2 genes in hepatocellular carcinoma diagnosis and prognosis. Zhang CY; Yang M World J Hepatol; 2022 May; 14(5):956-971. PubMed ID: 35721293 [TBL] [Abstract][Full Text] [Related]
43. Eukaryotic elongation factor-2 kinase expression is an independent prognostic factor in colorectal cancer. Ng TH; Sham KWY; Xie CM; Ng SSM; To KF; Tong JHM; Liu WYZ; Zhang L; Chan MTV; Wu WKK; Cheng CHK BMC Cancer; 2019 Jul; 19(1):649. PubMed ID: 31266475 [TBL] [Abstract][Full Text] [Related]
44. MicroRNA-1305 Inhibits the Stemness of LCSCs and Tumorigenesis by Repressing the UBE2T-Dependent Akt-Signaling Pathway. Wei X; You X; Zhang J; Zhou C Mol Ther Nucleic Acids; 2019 Jun; 16():721-732. PubMed ID: 31128423 [TBL] [Abstract][Full Text] [Related]
45. LncRNA PCAT6 is a predictor of poor prognosis of colorectal cancer. Han L; Li Z; Zhang P; Sheng M; Wang W; Sun Y; Sun D J Gastrointest Oncol; 2024 Feb; 15(1):190-202. PubMed ID: 38482211 [TBL] [Abstract][Full Text] [Related]
46. Comprehensive analysis of the potential role and prognostic value of sine oculis homeobox homolog family in colorectal cancer. Fang ZX; Li CL; Wu Z; Hou YY; Wu HT; Liu J World J Gastrointest Oncol; 2022 Nov; 14(11):2138-2156. PubMed ID: 36438701 [TBL] [Abstract][Full Text] [Related]
47. UBN2 promotes tumor progression via the Ras/MAPK pathway and predicts poor prognosis in colorectal cancer. Zhao YL; Zhong SR; Zhang SH; Bi JX; Xiao ZY; Wang SY; Jiao HL; Zhang D; Qiu JF; Zhang LJ; Huang CM; Chen XL; Ding YQ; Ye YP; Liang L; Liao WT Cancer Cell Int; 2019; 19():126. PubMed ID: 31110467 [TBL] [Abstract][Full Text] [Related]
48. UBE2T/STAT3 Signaling Promotes the Proliferation and Tumorigenesis in Retinoblastoma. Xu N; Cui Y; Shi H; Guo G; Sun F; Jian T; Rao H Invest Ophthalmol Vis Sci; 2022 Aug; 63(9):20. PubMed ID: 35980647 [TBL] [Abstract][Full Text] [Related]
49. Aberrant expression of stress-induced phosphoprotein 1 in colorectal cancer and its clinicopathologic significance. Zhang Z; Ren H; Yang L; Zhang X; Liang W; Wu H; Huang L; Kang J; Xu J; Zhai E; Cai S; He Y Hum Pathol; 2018 Sep; 79():135-143. PubMed ID: 29879402 [TBL] [Abstract][Full Text] [Related]
50. Quiescin Sulfhydryl Oxidase 2 Overexpression Predicts Poor Prognosis and Tumor Progression in Patients With Colorectal Cancer: A Study Based on Data Mining and Clinical Verification. Jiang T; Zheng L; Li X; Liu J; Song H; Xu Y; Dong C; Liu L; Wang H; Wang S; Wang R; Song J Front Cell Dev Biol; 2021; 9():678770. PubMed ID: 34858968 [No Abstract] [Full Text] [Related]
51. UBE2T silencing inhibited non-small cell lung cancer cell proliferation and invasion by suppressing the wnt/β-catenin signaling pathway. Liu J; Liu X Int J Clin Exp Pathol; 2017; 10(9):9482-9488. PubMed ID: 31966822 [TBL] [Abstract][Full Text] [Related]
52. UBE2T knockdown inhibits gastric cancer progression. Luo C; Yao Y; Yu Z; Zhou H; Guo L; Zhang J; Cao H; Zhang G; Li Y; Jiao Z Oncotarget; 2017 May; 8(20):32639-32654. PubMed ID: 28427240 [TBL] [Abstract][Full Text] [Related]
53. Li D; Zeng Y; Shen P; Lin X; Yang T; Chen B; Ma Z; Wang H Cancer Manag Res; 2021; 13():3123-3132. PubMed ID: 33859498 [TBL] [Abstract][Full Text] [Related]
54. PABPC1L depletion inhibits proliferation and migration via blockage of AKT pathway in human colorectal cancer cells. Wu YQ; Ju CL; Wang BJ; Wang RG Oncol Lett; 2019 Mar; 17(3):3439-3445. PubMed ID: 30867782 [TBL] [Abstract][Full Text] [Related]
55. Decreased E2F2 Expression Correlates with Poor Prognosis and Immune Infiltrates in Patients with Colorectal Cancer. Shang Y; Zhang Y; Liu J; Chen L; Yang X; Zhu Z; Li D; Deng Y; Zhou Z; Lu B; Fu CG J Cancer; 2022; 13(2):653-668. PubMed ID: 35069909 [TBL] [Abstract][Full Text] [Related]
56. Comprehensive analysis reveals TSPEAR as a prognostic biomarker in colorectal cancer. Xue D; Peng H; Li Z; Xu J; Ma H; Dang Y; Li F; Wang G; Sun Q J Cancer; 2024; 15(3):809-824. PubMed ID: 38213725 [No Abstract] [Full Text] [Related]
57. Expression and clinical significance of absent in melanoma 2 in colorectal cancer. Zhang Z; Dong X; Yang X; Wan D; Sun L; Gu M; Li M; Zhu Z; Wang J; Shang Z; He S Biomed Pharmacother; 2017 Oct; 94():843-849. PubMed ID: 28802238 [TBL] [Abstract][Full Text] [Related]
58. Prognostic value of ubiquitin-conjugating enzyme E2 S overexpression in hepatocellular carcinoma. Ma Y; Li K; Li S; Liang B; Liu Q; Mo Z Int J Biol Macromol; 2018 Nov; 119():225-231. PubMed ID: 30041036 [TBL] [Abstract][Full Text] [Related]
59. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer. Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444 [TBL] [Abstract][Full Text] [Related]
60. Overexpression of flavin-containing monooxygenase 5 predicts poor prognosis in patients with colorectal cancer. Zhang T; Yang P; Wei J; Li W; Zhong J; Chen H; Cao J Oncol Lett; 2018 Mar; 15(3):3923-3927. PubMed ID: 29456741 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]